ProQR Therapeutics Stock Forecast - Simple Moving Average
| PRQR Stock | USD 1.68 0.01 0.59% |
ProQR Stock outlook is based on your current time horizon. Although ProQR Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ProQR Therapeutics' systematic risk associated with finding meaningful patterns of ProQR Therapeutics fundamentals over time.
As of today, the RSI of ProQR Therapeutics' share price is approaching 38 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling ProQR Therapeutics, making its price go up or down. Momentum 38
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.49) | EPS Estimate Next Year (0.62) | Wall Street Target Price 8.875 | EPS Estimate Current Quarter (0.18) |
Using ProQR Therapeutics hype-based prediction, you can estimate the value of ProQR Therapeutics BV from the perspective of ProQR Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ProQR Therapeutics using ProQR Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ProQR using crowd psychology based on the activity and movement of ProQR Therapeutics' stock price.
ProQR Therapeutics Implied Volatility | 1.83 |
ProQR Therapeutics' implied volatility exposes the market's sentiment of ProQR Therapeutics BV stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ProQR Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ProQR Therapeutics stock will not fluctuate a lot when ProQR Therapeutics' options are near their expiration.
The Simple Moving Average forecasted value of ProQR Therapeutics BV on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.95. ProQR Therapeutics after-hype prediction price | USD 1.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ProQR Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 ProQR Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast ProQR Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ProQR Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ProQR Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ProQR Therapeutics' open interest, investors have to compare it to ProQR Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ProQR Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ProQR. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
ProQR Therapeutics Additional Predictive Modules
Most predictive techniques to examine ProQR price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ProQR using various technical indicators. When you analyze ProQR charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ProQR Therapeutics Simple Moving Average Price Forecast For the 29th of January
Given 90 days horizon, the Simple Moving Average forecasted value of ProQR Therapeutics BV on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.95.Please note that although there have been many attempts to predict ProQR Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ProQR Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ProQR Therapeutics Stock Forecast Pattern
| Backtest ProQR Therapeutics | ProQR Therapeutics Price Prediction | Buy or Sell Advice |
ProQR Therapeutics Forecasted Value
In the context of forecasting ProQR Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ProQR Therapeutics' downside and upside margins for the forecasting period are 0.02 and 6.29, respectively. We have considered ProQR Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of ProQR Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent ProQR Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.9623 |
| Bias | Arithmetic mean of the errors | 0.0254 |
| MAD | Mean absolute deviation | 0.0824 |
| MAPE | Mean absolute percentage error | 0.0399 |
| SAE | Sum of the absolute errors | 4.945 |
Predictive Modules for ProQR Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProQR Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ProQR Therapeutics After-Hype Price Density Analysis
As far as predicting the price of ProQR Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ProQR Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ProQR Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ProQR Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting ProQR Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ProQR Therapeutics' historical news coverage. ProQR Therapeutics' after-hype downside and upside margins for the prediction period are 0.09 and 6.43, respectively. We have considered ProQR Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ProQR Therapeutics is risky at this time. Analysis and calculation of next after-hype price of ProQR Therapeutics is based on 3 months time horizon.
ProQR Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ProQR Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProQR Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ProQR Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.69 | 4.61 | 0.14 | 0.01 | 12 Events / Month | 7 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.68 | 1.82 | 8.33 |
|
ProQR Therapeutics Hype Timeline
ProQR Therapeutics is at this time traded for 1.68. The entity has historical hype elasticity of 0.14, and average elasticity to hype of competition of -0.01. ProQR is projected to increase in value after the next headline, with the price projected to jump to 1.82 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 8.33%, whereas the daily expected return is at this time at -0.69%. The volatility of related hype on ProQR Therapeutics is about 51222.22%, with the expected price after the next announcement by competition of 1.67. The company has return on total asset (ROA) of (0.2402) % which means that it has lost $0.2402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0376) %, meaning that it created substantial loss on money invested by shareholders. ProQR Therapeutics' management efficiency ratios could be used to measure how well ProQR Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/28/2026, Return On Tangible Assets is likely to drop to -0.16. In addition to that, Return On Capital Employed is likely to drop to -0.22. At this time, ProQR Therapeutics' Other Current Assets are relatively stable compared to the past year. As of 01/28/2026, Net Tangible Assets is likely to grow to about 82.9 M, while Non Current Assets Total are likely to drop slightly above 8.9 M. Given the investment horizon of 90 days the next projected press release will be in about 12 days. Check out Historical Fundamental Analysis of ProQR Therapeutics to cross-verify your projections.ProQR Therapeutics Related Hype Analysis
Having access to credible news sources related to ProQR Therapeutics' direct competition is more important than ever and may enhance your ability to predict ProQR Therapeutics' future price movements. Getting to know how ProQR Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ProQR Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMMP | Immutep Ltd ADR | (0.10) | 5 per month | 2.87 | 0.14 | 7.41 | (5.41) | 31.54 | |
| EDIT | Editas Medicine | (0.01) | 24 per month | 0.00 | (0.17) | 6.56 | (9.13) | 21.57 | |
| CAPR | Capricor Therapeutics | (0.31) | 11 per month | 4.28 | 0.12 | 11.97 | (10.26) | 386.29 | |
| ACHV | Achieve Life Sciences | (0.18) | 9 per month | 0.00 | (0.03) | 5.86 | (6.40) | 24.72 | |
| ALLO | Allogene Therapeutics | (0.01) | 14 per month | 3.77 | 0.08 | 9.76 | (6.16) | 26.97 | |
| ARCT | Arcturus Therapeutics Holdings | (0.01) | 15 per month | 0.00 | (0.16) | 6.10 | (6.72) | 15.98 | |
| MREO | Mereo BioPharma Group | (0.07) | 8 per month | 0.00 | (0.01) | 16.33 | (9.52) | 101.95 | |
| VNDA | Vanda Pharmaceuticals | 0.20 | 10 per month | 4.87 | 0.12 | 11.39 | (6.34) | 39.51 | |
| TRDA | Entrada Therapeutics | 0.20 | 9 per month | 2.11 | 0.23 | 6.98 | (4.00) | 15.00 | |
| ZURA | Zura Bio Limited | 0.20 | 17 per month | 4.03 | 0.18 | 9.82 | (6.25) | 28.57 |
Other Forecasting Options for ProQR Therapeutics
For every potential investor in ProQR, whether a beginner or expert, ProQR Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ProQR Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ProQR. Basic forecasting techniques help filter out the noise by identifying ProQR Therapeutics' price trends.ProQR Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProQR Therapeutics stock to make a market-neutral strategy. Peer analysis of ProQR Therapeutics could also be used in its relative valuation, which is a method of valuing ProQR Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ProQR Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how ProQR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProQR Therapeutics shares will generate the highest return on investment. By undertsting and applying ProQR Therapeutics stock market strength indicators, traders can identify ProQR Therapeutics BV entry and exit signals to maximize returns.
ProQR Therapeutics Risk Indicators
The analysis of ProQR Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ProQR Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting proqr stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.44 | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ProQR Therapeutics
The number of cover stories for ProQR Therapeutics depends on current market conditions and ProQR Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ProQR Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ProQR Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ProQR Therapeutics Short Properties
ProQR Therapeutics' future price predictability will typically decrease when ProQR Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ProQR Therapeutics BV often depends not only on the future outlook of the potential ProQR Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProQR Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 81.7 M | |
| Cash And Short Term Investments | 149.4 M |
Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.